EBA
ZYME icon

Eagle Bay Advisors’s Zymeworks ZYME Stock Holding History

Eagle Bay Advisors’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-110
Closed -$1.61K – 977
2024
Q4 		$1.61K Hold
110
– – ﹤0.01% 904
2024
Q3 		$1.38K Hold
110
– – ﹤0.01% 1276
2024
Q2 		$936 Hold
110
– – ﹤0.01% 942
2024
Q1 		$1.16K Hold
110
– – ﹤0.01% 918
2023
Q4 		$1.14K Hold
110
– – ﹤0.01% 778
2023
Q3 		$697 Hold
110
– – ﹤0.01% 811
2023
Q2 		$950 Hold
110
– – ﹤0.01% 804
2023
Q1 		$994 Hold
110
– – ﹤0.01% 817
2022
Q4 		$865 Hold
110
– – ﹤0.01% 840
2022
Q3 		$1K Hold
110
– – ﹤0.01% 888
2022
Q2 		$583 Buy
+110
New +$665 ﹤0.01% 987
2022
Q1 		– Sell
-110
Closed -$2K – 1004
2021
Q4 		$2K Buy
+110
New +$2.29K ﹤0.01% 953

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Eagle Bay Advisors's ZYME Position: Q1 2025 in Review

Eagle Bay Advisors sold out of Zymeworks (ZYME) in Q1 2025, closing a stake of 110 shares — an estimated $1.61K sold.

Eagle Bay Advisors first reported a position in ZYME in Q4 2021 and held it in 12 quarters. The position peaked at $2K in Q4 2021. 184 funds tracked by Wall St. Rank hold ZYME as of Q1 2025.

  • Eagle Bay Advisors reported no remaining Zymeworks position as of Q1 2025 after selling out during the quarter.
  • Eagle Bay Advisors sold 110 Zymeworks shares in Q1 2025, an estimated $1.61K.
  • Eagle Bay Advisors first reported a position in Zymeworks in Q4 2021 and held it in 12 quarters.
  • Eagle Bay Advisors's Zymeworks position peaked at $2K in Q4 2021.
  • 184 funds tracked by Wall St. Rank held Zymeworks as of Q1 2025.

Based on Eagle Bay Advisors's 13F filing for Q1 2025, filed 5 May 2025.